Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ole Hvilsted Olsen

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Frontiers in Bioscience (Landmark Edition)|May 31, 2011
Allosteric activation of coagulation factor VIIaEgon Persson, Ole Hvilsted Olsen
European Biophysics Journal : EBJ|November 30, 2006
Computational study of coagulation factor VIIa's affinity for phospholipid membranesOlivier Taboureau, Ole Hvilsted Olsen
Frontiers in Bioscience (Landmark Edition)|May 31, 2011
Tissue factor and factor VIIa cross-species compatibilityTom Knudsen, Ole Hvilsted Olsen, Lars Christian Petersen
Journal of Medicinal Chemistry|January 9, 2004
Synthesis and structure-activity relationship for a novel class of potent and selective carbamoyl-triazole based inhibitors of hormone sensitive lipaseSøren Ebdrup, Lotte Gottlieb Sørensen, Ole Hvilsted Olsen, et al.
Biological Chemistry|February 26, 2013
Evaluation of the metal binding sites in a recombinant coagulation factor VIII identifies two sites with unique metal binding propertiesLars Anders Svensson, Lars Thim, Ole Hvilsted Olsen, et al.
Chemical Biology & Drug Design|August 23, 2006
Design of novispirin antimicrobial peptides by quantitative structure-activity relationshipOlivier Taboureau, Ole Hvilsted Olsen, Jesper Duus Nielsen, et al.
Biological Chemistry|October 7, 2009
Coagulation factor XIII variants with altered thrombin activation ratesMette Dahl Andersen, Marianne Kjalke, Susanne Bang, et al.
Journal of Thrombosis and Haemostasis : JTH|December 20, 2021
The functional role of the autolysis loop in the regulation of factor X upon hemostatic responseAmalie Carnbring Bonde, Jacob Lund, Jens Jacob Hansen, et al.
The Journal of Biological Chemistry|March 17, 2004
Structure-based design of selective and potent inhibitors of protein-tyrosine phosphatase betaIda Katrine Lund, Henrik Sune Andersen, Lars Fogh Iversen, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Frontiers in Bioscience (Landmark Edition)|May 31, 2011
Allosteric activation of coagulation factor VIIaEgon Persson, Ole Hvilsted Olsen
European Biophysics Journal : EBJ|November 30, 2006
Computational study of coagulation factor VIIa's affinity for phospholipid membranesOlivier Taboureau, Ole Hvilsted Olsen
Frontiers in Bioscience (Landmark Edition)|May 31, 2011
Tissue factor and factor VIIa cross-species compatibilityTom Knudsen, Ole Hvilsted Olsen, Lars Christian Petersen
Journal of Medicinal Chemistry|January 9, 2004
Synthesis and structure-activity relationship for a novel class of potent and selective carbamoyl-triazole based inhibitors of hormone sensitive lipaseSøren Ebdrup, Lotte Gottlieb Sørensen, Ole Hvilsted Olsen, et al.
Biological Chemistry|February 26, 2013
Evaluation of the metal binding sites in a recombinant coagulation factor VIII identifies two sites with unique metal binding propertiesLars Anders Svensson, Lars Thim, Ole Hvilsted Olsen, et al.
Chemical Biology & Drug Design|August 23, 2006
Design of novispirin antimicrobial peptides by quantitative structure-activity relationshipOlivier Taboureau, Ole Hvilsted Olsen, Jesper Duus Nielsen, et al.
Biological Chemistry|October 7, 2009
Coagulation factor XIII variants with altered thrombin activation ratesMette Dahl Andersen, Marianne Kjalke, Susanne Bang, et al.
Journal of Thrombosis and Haemostasis : JTH|December 20, 2021
The functional role of the autolysis loop in the regulation of factor X upon hemostatic responseAmalie Carnbring Bonde, Jacob Lund, Jens Jacob Hansen, et al.
The Journal of Biological Chemistry|March 17, 2004
Structure-based design of selective and potent inhibitors of protein-tyrosine phosphatase betaIda Katrine Lund, Henrik Sune Andersen, Lars Fogh Iversen, et al.
Pageof 1